Inventor · disambiguated record
Craig Husfeld
Also filed as: HUSFELD CRAIG · HUSFELD CRAIG O
85 granted patents·20 pending applications·1,264 citations·filing 2003–2025
99Inventor score
Files withTHERAVANCE INC35CONCENTRIC ANALGESICS INC13JENKINS THOMAS E11SIGNATURE THERAPEUTICS INC11JI YUHUA10
Top patents by PatentIndex Score
105 records- 0199US7288657B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Oct 30, 2007·71 cites·18 claims
- 0298US11247969B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2020·Granted Feb 15, 2022·6 cites·10 claims
- 0397US8497237B2Compositions comprising enzyme-cleavable oxycodone prodrugJENKINS THOMAS E·Filed 2012·Granted Jul 30, 2013·27 cites·31 claims
- 0497US8053448B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2011·Granted Nov 8, 2011·24 cites·2 claims
- 0597US8034946B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2010·Granted Oct 11, 2011·28 cites·2 claims
- 0697US7910608B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Mar 22, 2011·32 cites·4 claims
- 0797US7585879B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Sep 8, 2009·35 cites·12 claims
- 0897US7550595B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Jun 23, 2009·37 cites·22 claims
- 0997US7524965B2Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activityTHERAVANCE INC·Filed 2007·Granted Apr 28, 2009·44 cites·10 claims
- 1097US7521041B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Apr 21, 2009·27 cites·22 claims
- 1197US7491736B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Feb 17, 2009·29 cites·24 claims
- 1297US7265133B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Sep 4, 2007·65 cites·20 claims
- 1397US7262205B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Aug 28, 2007·50 cites·21 claims
- 1496US10570092B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2019·Granted Feb 25, 2020·8 cites·5 claims
- 1596US10343995B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Jul 9, 2019·9 cites·23 claims
- 1696US9452161B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2016·Granted Sep 27, 2016·11 cites·9 claims
- 1796US9139612B2Active agent prodrugs with heterocyclic linkersJENKINS THOMAS E·Filed 2012·Granted Sep 22, 2015·20 cites·29 claims
- 1896US9040032B2Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereofSIGNATURE THERAPEUTICS INC·Filed 2012·Granted May 26, 2015·27 cites·51 claims
- 1996US8569228B2Compositions comprising enzyme-cleavable oxycodone prodrugJENKINS THOMAS E·Filed 2012·Granted Oct 29, 2013·27 cites·31 claims
- 2096US7803812B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2009·Granted Sep 28, 2010·19 cites·30 claims
- 2196US7479562B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Jan 20, 2009·39 cites·24 claims
- 2296US7141671B2Biphenyl derivativesTHERAVANCE INC·Filed 2004·Granted Nov 28, 2006·145 cites·42 claims
- 2395US10106503B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2018·Granted Oct 23, 2018·9 cites·25 claims
- 2495US9926272B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE BIOPHARMA R&D IP LLC·Filed 2016·Granted Mar 27, 2018·9 cites·7 claims
- 2595US9283183B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2014·Granted Mar 15, 2016·12 cites·17 claims
- 2695US8912334B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2013·Granted Dec 16, 2014·13 cites·6 claims
- 2795US8685916B2Opioid prodrugs with heterocyclic linkersJENKINS THOMAS E·Filed 2012·Granted Apr 1, 2014·30 cites·123 claims
- 2895US8557997B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2012·Granted Oct 15, 2013·13 cites·6 claims
- 2995US8273894B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2012·Granted Sep 25, 2012·15 cites·14 claims
- 3095US8173815B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2011·Granted May 8, 2012·15 cites·10 claims
- 3195US8017783B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Sep 13, 2011·17 cites·13 claims
- 3295US7629336B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Dec 8, 2009·29 cites·12 claims
- 3395US7501442B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2005·Granted Mar 10, 2009·40 cites·23 claims
- 3494US7879879B2Biphenyl derivativesTHERAVANCE INC·Filed 2006·Granted Feb 1, 2011·19 cites·7 claims
- 3594US7687521B2Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activityTHERAVANCE INC·Filed 2009·Granted Mar 30, 2010·23 cites·11 claims
- 3694US7683173B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2008·Granted Mar 23, 2010·23 cites·21 claims
- 3793US9585963B2Compositions comprising enzyme-cleavable opioid prodrugs and inhibitors thereofSIGNATURE THERAPEUTICS INC·Filed 2015·Granted Mar 7, 2017·7 cites·47 claims
- 3893US8962547B2Compositions comprising enzyme-cleavable oxycodone prodrugSIGNATURE THERAPEUTICS INC·Filed 2013·Granted Feb 24, 2015·15 cites·12 claims
- 3992US7851631B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Dec 14, 2010·15 cites·17 claims
- 4092US7728144B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2006·Granted Jun 1, 2010·20 cites·17 claims
- 4191US9359316B1Prodrugs of phenolic TRPV1 agonistsCONCENTRIC ANALGESICS INC·Filed 2015·Granted Jun 7, 2016·18 cites·1 claims
- 4291US8134006B2Dialkylphenyl compounds having β2 adrenergic receptor agonist and muscarinic receptor antagonist activityCOLSON PIERRE-JEAN·Filed 2010·Granted Mar 13, 2012·15 cites·8 claims
- 4391US7851632B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2007·Granted Dec 14, 2010·14 cites·14 claims
- 4490US7868175B2Biphenyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2009·Granted Jan 11, 2011·11 cites·13 claims
- 4589US9095627B2Opioid prodrugs with heterocyclic linkersSIGNATURE THERAPEUTICS INC·Filed 2014·Granted Aug 4, 2015·11 cites·114 claims
- 4687US9499581B2Compositions comprising enzyme-cleavable oxycodone prodrugSIGNATURE THERAPEUTICS INC·Filed 2015·Granted Nov 22, 2016·5 cites·14 claims
- 4787US8067439B2Biphenyl compounds useful as muscarinic receptor antagonistsMAMMEN MATHAI·Filed 2010·Granted Nov 29, 2011·8 cites·17 claims
- 4887US7834185B2Quaternary ammonium diphenylmethyl compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2008·Granted Nov 16, 2010·8 cites·43 claims
- 4986US8501776B2Biphenyl compounds useful as muscarinic receptor antagonistsJI YUHUA·Filed 2010·Granted Aug 6, 2013·7 cites·13 claims
- 5086US8017617B2Amidine-containing compounds useful as muscarinic receptor antagonistsTHERAVANCE INC·Filed 2008·Granted Sep 13, 2011·7 cites·22 claims
Showing the top 50 of 105 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →